Nature Reviews Microbiology

Papers
(The H4-Index of Nature Reviews Microbiology is 90. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)
ArticleCitations
SARS-CoV-2 variants, spike mutations and immune escape2815
Long COVID: major findings, mechanisms and recommendations1728
Antibiotic resistance in the environment1127
Infectious disease in an era of global change758
SARS-CoV-2 pathogenesis551
Transmissibility and transmission of respiratory viruses513
The biofilm life cycle: expanding the conceptual model of biofilm formation502
The evolution of SARS-CoV-2476
Tackling the emerging threat of antifungal resistance to human health472
Tolerance and resistance of microbial biofilms460
Life and death in the soil microbiome: how ecological processes influence biogeochemistry416
Molecular mechanisms of antibiotic resistance revisited400
An evolving view on biogeochemical cycling of iron393
Prevotella diversity, niches and interactions with the human host337
The human virome: assembly, composition and host interactions323
Horizontal gene transfer and adaptive evolution in bacteria319
Structural biology of SARS-CoV-2 and implications for therapeutic development315
Pathogenesis of human cytomegalovirus in the immunocompromised host304
Electromicrobiology: the ecophysiology of phylogenetically diverse electroactive microorganisms299
Interactions between bacterial and phage communities in natural environments286
Climate change impacts on plant pathogens, food security and paths forward285
Bile acids and the gut microbiota: metabolic interactions and impacts on disease284
Soil microbiomes and one health279
The role of vaccines in combatting antimicrobial resistance278
Microbial volatile organic compounds in intra-kingdom and inter-kingdom interactions273
The biofilm matrix: multitasking in a shared space264
Bacillus subtilis biofilm formation and social interactions263
SARS-CoV-2 variant biology: immune escape, transmission and fitness263
Pseudomonas aeruginosa adaptation and evolution in patients with cystic fibrosis262
Beyond horizontal gene transfer: the role of plasmids in bacterial evolution253
Priority effects in microbiome assembly245
Skeletal infections: microbial pathogenesis, immunity and clinical management242
The stringent response and physiological roles of (pp)pGpp in bacteria235
Biology and evolution of bacterial toxin–antitoxin systems229
Influenza virus and SARS-CoV-2: pathogenesis and host responses in the respiratory tract222
Nutritional immunity: the battle for nutrient metals at the host–pathogen interface221
Microbial diversity in extreme environments219
Bacterial motility: machinery and mechanisms218
Carbohydrate-active enzymes (CAZymes) in the gut microbiome216
Microbiome-based therapeutics212
Mass spectrometry-based metabolomics in microbiome investigations211
Anti-tuberculosis treatment strategies and drug development: challenges and priorities205
Infections at the maternal–fetal interface: an overview of pathogenesis and defence202
Staphylococcus aureus host interactions and adaptation200
The microbiome-shaping roles of bacteriocins197
The rumen microbiome: balancing food security and environmental impacts196
Immune evasion and provocation by Mycobacterium tuberculosis191
Evasion of plant immunity by microbial pathogens181
Epstein–Barr virus and multiple sclerosis181
Examining horizontal gene transfer in microbial communities179
The dynamic lung microbiome in health and disease175
Treatment strategies for cryptococcal infection: challenges, advances and future outlook173
Microbial evolution and transitions along the parasite–mutualist continuum173
SARS-CoV-2 variant evasion of monoclonal antibodies based on in vitro studies172
Human papillomaviruses: diversity, infection and host interactions170
Microbial production of advanced biofuels162
Physical properties of the bacterial outer membrane154
Antibiofilm activity of host defence peptides: complexity provides opportunities151
Composition and functions of bacterial membrane vesicles148
Trichoderma: a multipurpose, plant-beneficial microorganism for eco-sustainable agriculture144
The WHO fungal priority pathogens list as a game-changer141
Salmonella Typhimurium and inflammation: a pathogen-centric affair141
When anaerobes encounter oxygen: mechanisms of oxygen toxicity, tolerance and defence136
Ecology, evolution and spillover of coronaviruses from bats129
Ecology and impacts of white-nose syndrome on bats129
Architecture of bacterial respiratory chains128
The highly diverse antiphage defence systems of bacteria127
The marine nitrogen cycle: new developments and global change127
Microbially mediated metal corrosion125
Toxoplasma gondii infection and its implications within the central nervous system125
The interplay between microbial communities and soil properties123
The ecological roles of bacterial chemotaxis119
Gradients and consequences of heterogeneity in biofilms116
The effects of the COVID-19 pandemic on community respiratory virus activity113
Influenza lineage extinction during the COVID-19 pandemic?104
Architecture of the dynamic fungal cell wall103
Host specificity of the gut microbiome103
Revisiting the rules of life for viruses of microorganisms102
The gut–liver axis and gut microbiota in health and liver disease102
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota101
Diversity and evolution of the animal virome101
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity99
Structural biology of CRISPR–Cas immunity and genome editing enzymes98
Microbiota succession throughout life from the cradle to the grave96
Microbiota-mediated colonization resistance: mechanisms and regulation95
Staphylococcus epidermidis and its dual lifestyle in skin health and infection94
Marine biofilms: diversity, interactions and biofouling94
Cells within cells: Rickettsiales and the obligate intracellular bacterial lifestyle92
Pathogenesis, epidemiology and control of Group A Streptococcus infection92
Towards SARS-CoV-2 serotypes?90
0.057255029678345